From: Optimal management of adults with pharyngitis – a multi-criteria decision analysis
Group | Criterion | Baseline priority | Preferred option, baseline | Threshold value(s) |
---|---|---|---|---|
1 | Prevent complications | 0.25 | NO TEST, NO TREAT | NO TEST, NO TREAT < 0.406 < RAPID STREP & CULTURE or CULTURE |
1 | Avoid over- vs under use of antibiotics | 0.5 | NO TEST, NO TREAT | CULTURE or RAPID STREP & CULTURE < 0.375 < NO TEST, NO TREAT |
2 | Prevent complications | 0.25 | CULTURE | NO TEST, NO TREAT < 0.162 < CULTURE < 0.429 < RAPID STREP & CULTURE |
2 | Avoid side effects | 0.25 | CULTURE | CULTURE < 0.457 < NO TEST, NO TREAT |
2 | Optimal antibiotic use | 0.25 | CULTURE | RAPID STREP & CULTURE < 0.133 < CULTURE < 0.619 < NO TEST, NO TREAT |
2 | Avoid over- vs under use of antibiotics | 0.5 | CULTURE | RAPID STREP & CULTURE < 0.455 < CULTURE < 0.674 < NO TEST, NO TREAT |
3 | Prevent complications | 0.25 | RAPID STREP & CULTURE | NO TEST, NO TREAT < 0.15 < RAPID STREP & CULTURE |
3 | Avoid side effects | 0.25 | RAPID STREP & CULTURE | RAPID STREP & CULTURE < 0.354 < NO TEST, NO TREAT |
3 | Optimal antibiotic use | 0.25 | RAPID STREP & CULTURE | RAPID STREP & CULTURE < 0.389 < CULTURE |
3 | Avoid over- vs under use of antibiotics | 0.5 | RAPID STREP & CULTURE | EMPIRIC TREATMENT < 0.264 < RAPID STREP & CULTURE < 0.565 < NO TEST, NO TREAT |
3 | Minor penicillin side effect vs anaphylaxis | 0.125 | RAPID STREP & CULTURE | RAPID STREP & CULTURE < 0.44 < NO TEST, NO TREAT |
4 | Avoid treatment side effects | 0.25 | RAPID STREP & CULTURE | RAPID STREP & CULTURE < 0.545 < NO TEST, NO TREAT |
4 | Shorten duration of illness | 0.25 | RAPID STREP & CULTURE | RAPID STREP & CULTURE < 0.864 < CULTURE |
4 | Avoid over- vs under use of antibiotics | 0.5 | RAPID STREP & CULTURE | EMPIRIC TREATMENT < 0.264 < RAPID STREP & CULTURE < 0.737 < NO TEST, NO TREAT |